ADC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	261.34	250.87	278.6	326.44	466.54
Cash & Short-Term Investments	261.34	250.87	278.6	326.44	466.54
Cash Growth	4.17%	-9.95%	-14.66%	-30.03%	6.23%
Accounts Receivable	29.12	20.32	25.18	72.97	30.22
Inventory	4.18	2.25	16.18	18.56	11.12
Other Current Assets	11.7	17.82	16.33	28.04	17.3
Total Current Assets	306.34	291.25	336.29	446.02	525.18
Net Property, Plant & Equipment	1.3	13.43	16.13	9.98	11.23
Other Intangible Assets	-	-	-	14.36	13.58
Long-Term Investments	-	-	1.65	31.15	41.24
Other Long-Term Assets	15.52	17.3	0.71	27.66	26.74
Total Assets	323.15	321.98	354.78	529.17	617.97
Accounts Payable	9.18	18.03	15.57	12.35	12.08
Accrued Expenses	57.99	62.44	52.1	-	3.75
Short-Term Debt	-	-	-	-	6.58
Current Portion of Long-Term Debt	3	-	-	12.47	-
Current Portion of Leases	-	-	-	1.1	1.03
Other Current Liabilities	-	-	-	73.04	50.5
Total Current Liabilities	70.16	80.47	67.67	98.96	73.94
Long-Term Debt	112.45	113.63	112.73	97.24	-
Long-Term Leases	1.03	8	10.18	6.56	6.99
Other Long-Term Liabilities	325.34	322.53	312.45	212.35	222.32
Total Long-Term Liabilities	438.82	444.15	435.36	341.48	377.95
Total Liabilities	508.98	524.62	503.03	440.44	451.88
Common Stock	11.08	8.43	7.31	7.31	6.45
Treasury Stock	-0.21	-0.22	-0.54	-0.68	-0.13
Additional Paid-in Capital	1,440	1,284	1,181	1,163	1,084
Accumulated Other Comprehensive Income	-0.52	-1.42	-0.09	-0.36	0.18
Retained Earnings	-1,636	-1,493	-1,335	-1,081	-924.89
Shareholders' Equity	-185.83	-202.64	-148.25	88.73	166.09
Total Liabilities & Equity	323.15	321.98	354.78	529.17	617.97
Total Debt	116.49	121.63	122.91	117.38	14.6
Net Cash (Debt)	144.85	129.24	155.69	209.07	451.95
Net Cash Growth	12.08%	-16.99%	-25.53%	-53.74%	4.59%
Net Cash Per Share	1.14	1.33	1.91	2.67	5.89
Book Value	-185.83	-202.64	-148.25	88.73	166.09
Book Value Per Share	-1.46	-2.09	-1.81	1.14	2.16
Tangible Book Value	-185.83	-202.64	-148.25	74.37	152.51
Tangible Book Value Per Share	-1.46	-2.09	-1.81	0.95	1.99

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q